Early Impact of the COVID-19 Pandemic on Acute Stroke Treatment Delays.
Can J Neurol Sci
; 48(1): 122-126, 2021 Jan.
Article
in English
| MEDLINE | ID: covidwho-2264826
ABSTRACT
This is an observational cohort study comparing 156 patients evaluated for acute stroke between March 30 and May 31, 2020 at a comprehensive stroke center with 138 patients evaluated during the corresponding time period in 2019. During the pandemic, the proportion of COVID-19 positive patients was low (3%), the time from symptom onset to hospital presentation was significantly longer, and a smaller proportion of patients underwent reperfusion therapy. Among patients directly evaluated at our institution, door-to-needle and door-to-recanalization metrics were significantly longer. Our findings support concerns that the current pandemic may have a negative impact on the management of acute stroke.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Thrombolytic Therapy
/
Thrombectomy
/
Time-to-Treatment
/
Ischemic Stroke
/
Hemorrhagic Stroke
/
COVID-19
Type of study:
Cohort study
/
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
North America
Language:
English
Journal:
Can J Neurol Sci
Year:
2021
Document Type:
Article
Affiliation country:
Cjn.2020.160
Similar
MEDLINE
...
LILACS
LIS